Literature DB >> 3428498

Complement in type 1 (insulin-dependent) diabetes.

G Senaldi, B A Millward, M J Hussein, D Pyke, R D Leslie, D Vergani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3428498     DOI： 10.1007/BF00275751

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.

Authors:  D Vergani; L Wells; V F Larcher; B A Nasaruddin; E T Davies; G Mieli-Vergani; A P Mowat
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

Review 2.  Methods to detect and quantitate complement activation.

Authors:  N R Cooper; G R Nemerow; J T Mayes
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.

Authors:  H Milgrom; J G Curd; R A Kaplan; H J Müller-Eberhard; J H Vaughan
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  The complement system in type 1 (insulin-dependent) diabetes.

Authors:  J A Charlesworth; V Timmermans; J Golding; L V Campbell; P W Peake; B A Pussell; D Wakefield; N Howard
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

5.  Clinical application of a new nephelometric technique to measure complement activation.

Authors:  D Vergani; L Bevis; B A Nasaruddin; G Mieli-Vergani; D E Tee
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

6.  Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course.

Authors:  A J Swaak; A van Rooyen; C Vogelaar; M Pillay; E Hack
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631
  6 in total
  1 in total

1.  Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.

Authors:  G Senaldi; B A Millward; M J Hussain; D A Pyke; R D Leslie; D Vergani
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.